Results 11 to 20 of about 185,596 (291)

Tumor Circulating DNA

open access: yes, 2021
Analysis of tutor circulating DNA using Next Generation ...
Alexandru Salceanu (9303227)
openaire   +2 more sources

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA [PDF]

open access: yesMolecular Cancer, 2019
Hepatocellular carcinoma (HCC) is one of the most common cancers and a leading cause of death worldwide. Due to latent liver disease, late diagnosis, and nonresponse to systemic treatments, surgical resection and/or biopsy specimens are still generally ...
Qianwei Ye   +3 more
doaj   +3 more sources

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer

open access: yesJournal of Ovarian Research, 2017
Limited understanding of ovarian cancer (OC) genome portrait has hindered the therapeutic advances. The serial monitoring of tumor genotypes is becoming increasingly attainable with circulating cell-free DNA (cf-DNA) and circulating tumor cells (CTCs ...
Xianliang Cheng   +3 more
doaj   +2 more sources

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility [PDF]

open access: yesClinical Cancer Research, 2015
Abstract Recent technological advances have enabled the detection and detailed characterization of circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) in blood samples from patients with cancer. Often referred to as a “liquid biopsy,” CTCs and ctDNA are expected to provide real-time monitoring of tumor evolution and ...
Ignatiadis, Michail   +2 more
openaire   +4 more sources

Circulating Tumor DNA

open access: yesThe Journal of Molecular Diagnostics, 2023
For patients with BRAF wild-type stage III and IV melanoma, there is an urgent clinical need to identify prognostic biomarkers and biomarkers predictive of treatment response.
Lauren G. Aoude   +13 more
openaire   +2 more sources

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA

open access: yesTumor Biology, 2018
Biomarkers are the key to personalized treatment in patients with breast cancer. While tissue biomarkers are most useful in determining prognosis and upfront predicting response to therapy, circulating protein biomarkers such as CA 15-3 and ...
Michael J Duffy   +2 more
doaj   +2 more sources

Liquid Biopsy as a Method for Minimally Invasive Diagnosis of Thyroid Cancer [PDF]

open access: yesКлиническая практика, 2023
Thyroid cancer is the 9th most common cancer in the world. The five-year survival rate for this disease is over 98%. However, in some patients there are cases of rapidly progressive treatment-resistant cancer that cannot be differed from poor-invasive ...
Tagir I. Rakhmatullin   +3 more
doaj   +1 more source

Clinical Application of Circulating Tumor DNA Analysis [PDF]

open access: yes, 2022
Liquid biopsy using circulating tumor DNA helps overcome the limitations of conventional tissue testing. Non-invasive molecular profiling using circulating tumor DNA is increasingly being used to diagnose cancer, stratify risk, and select targeted ...
이승태, 원동주, 신새암
core   +1 more source

Supplementary Figure from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma

open access: yes, 2021
Supplementary Figure from Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell ...
John N. Waldron (15032258)   +18 more
core   +7 more sources

Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma

open access: yesBiosensors, 2022
While patients with resectable pancreatic ductal adenocarcinoma (PDAC) show improved survival compared to their non-resectable counterparts, survival remains low owing to occult metastatic disease and treatment resistance.
Pablo J. Dopico   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy